Volume 22, Issue 3, 15 March 2015, Pages 362–368
Scopoletin has a potential activity for anti-aging via autophagy in human lung fibroblasts
- Received 21 May 2014, Revised 4 January 2015, Accepted 8 January 2015, Available online 4 February 2015
Abstract
Autophagy
was known to be associated with aging in addition to cancer and
neurodegeneration. The effects of scopoletin on autophagy and anti-aging
were investigated in human lung fibroblast cell line, IMR 90. Here we
show that scopoletin induces autophagy. It is also identified that the
modulation of p53 by scopoletin are related to the induction of
autophagy. Moreover, the level of SA-β-Gal staining, an aging marker, is
reduced by scopoletin. In addition, while the expression levels of
histone deacetylases such as HDAC1, SIRT1 and SIRT6 are increased in IMR
90 cells in the presence of scopoletin, the expression levels of
histone acetyltransferases are decreased. Furthermore, scopoletin
enhances the level of transcription factors such as Nrf-2and p-FoxO1
related to anti-aging. In addition, scopoletin modulates the
reprogramming proteins. Therefore, these findings suggest that
scopoletin could exert a positive effect on anti-aging related to
autophagy through modulation of p53 in human lung fibroblasts.
Keywords
- Scopoletin;
- p53;
- HDAC1;
- Autophagy;
- Aging;
- IMR 90
Copyright © 2015 Elsevier GmbH. All rights reserved.